Finance

Lists
019170:KRX
Shinpoong Pharmaceutical Co Ltd
9 540,00 KRW
-0,62%
(-60,00) 1D
19-окт., 15:30:26 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 019170...
Open
9 200 KRW
High
9 550 KRW
Low
9 180 KRW
Mkt. cap
528,35 млд
Avg. vol.
479,47 миң
Volume
151,06 миң
52-wk high
15 900 KRW
52-wk low
6 310 KRW
EPS
-20 KRW
Shares outstanding
52,42 млн
No. of employees
656
Open
9 200 KRW
High
9 550 KRW
Low
9 180 KRW
Mkt. cap
528,35 млд
Avg. vol.
479,47 миң
Volume
151,06 миң
52-wk high
15 900 KRW
52-wk low
6 310 KRW
EPS
-20 KRW
Shares outstanding
52,42 млн
No. of employees
656
News stories
From web sources and news partners
marketscreener.com
marketscreener.com
·
27 мүнөт мурун
Nasdaq 100 Climbs on AI Trade Revival After Rout
Simply Wall Street
Simply Wall Street
·
46 мүнөт мурун
The Bet Andersons Holders Made
About Shinpoong Pharmaceutical Co Ltd
CEOYoo Je-man
Employees656
Founded1962
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
62,61 млд
58,04 млд
54,53 млд
63,89 млд
Cost of goods sold
33,91 млд
33,04 млд
33,12 млд
36,90 млд
Cost of revenue
33,91 млд
33,04 млд
33,12 млд
36,90 млд
Research and development expenses
2,39 млд
1,77 млд
4,19 млд
2,89 млд
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18,41 млд
19,16 млд
18,01 млд
30,48 млд
Operating expense
21,48 млд
21,14 млд
21,77 млд
35,02 млд
Total operating expenses
55,39 млд
54,17 млд
54,89 млд
71,92 млд
Operating income
7,22 млд
3,87 млд
-363,22 млн
-8,03 млд
Other non operating income
37,58 млн
56,74 млн
-42,52 млн
32,83 млн
EBT including unusual items
7,26 млд
302,61 млн
439,87 млн
-8,00 млд
EBT excluding unusual items
7,26 млд
3,25 млд
423,63 млн
-8,01 млд
Income tax expense
847,52 млн
-147,88 млн
70,67 млн
-18,14 млн
Effective tax rate
11,67%
-48,87%
16,07%
0,23%
Other operating expenses
43,68 млн
-434,64 млн
105,86 млн
379,89 млн
Net income
6,38 млд
461,37 млн
358,51 млн
-8,01 млд
Net profit margin
10,19%
0,79%
0,66%
-12,54%
Earnings per share
-
-
-
-
Interest and investment income
208,75 млн
200,34 млн
246,20 млн
432,18 млн
Interest expense
-642,57 млн
-671,63 млн
-862,72 млн
-856,95 млн
Net interest expenses
-433,82 млн
-471,28 млн
-616,52 млн
-424,77 млн
Depreciation and amortization charges
528,97 млн
372,83 млн
362,48 млн
332,80 млн
EBITDA
10,17 млд
6,67 млд
2,42 млд
-5,26 млд
Gain or loss from assets sale
-19,00 миң
-1,82 млн
-12,35 млн
-6,89 млн
AI content may include mistakes. Learn more
Google колдонмолору